Bluebird Bio Inc (BLUE) Inventory Turnover Ratio, from first quarter 2025 to first quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Bluebird Bio Inc   (NASDAQ: BLUE)
 

Bluebird Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2025, Bluebird Bio Inc 's inventory turnover ratio sequentially decreased to 1.29 in the first quarter 2025, unsurprisingly, as the Bluebird Bio Inc markets continue to deteriorate, and BLUE's faces growing challenges to bring down its inventories. Bluebird Bio Inc 's average inventory processing period in the Mar 31 2025 quarter, has increased to 283 days, from 186 days, in the Dec 31 2024 quarter.

Within Healthcare sector 297 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 1305, from total ranking in the fourth quarter 2024 at 1492.

BLUE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bluebird Bio Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BLUE Inventory Turnover Ratio (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Inventory Growth 174.82 % 183.68 % 157.26 % 144.32 % 695.62 %
Y / Y Cost of Sales Growth -52.69 % 136.6 % 7.54 % 202.66 % 666.11 %
Inventory Turnover Ratio (TTM) 1.29 1.96 2.17 2.8 2.55
BLUE's Total Ranking # 1305 # 1492 # 1285 # 1195 # 1154
Average inventory processing period 284 186 168 130 143
Seq. Inventory Growth 28.09 % 20.53 % 61.85 % 9.98 % 32.23 %
Seq. Cost of Sales Growth -46.3 % 93.44 % -59.3 % 11.92 % 168.52 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 21
Healthcare Sector # 298
Overall Market # 1305

Inventory Turnover Ratio Statistics
High Average Low
2.8 2.16 1.29
(Jun 30 2024)   (Mar 31 2025)



BLUE Company Profile >> Back to BLUE Efficiency Comparisons >> Compare BLUE Inventory Turnover Ratio to its Competitors

Financial Statements
Bluebird Bio Inc 's Inventories $ 83 Millions Visit BLUE's Balance sheet
Bluebird Bio Inc 's Cost of Revenues TTM $ 76 Millions Visit BLUE's Income Statement
What are BLUE's Sales? Visit BLUE's Sales by Segment

Other Inventory Turnover Ratios
Bluebird Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BLUE's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BLUE's Competitors
Inventory Turnover Ratio for BLUE's Suppliers
Inventory Turnover Ratio for BLUE's Customers

You may also want to know
BLUE's Sales Growth Rates BLUE's Pe Price to earnings ratio BLUE's Receivables Turnover Ratio BLUE's Stock Quote
BLUE's Net Income Growth Rates BLUE's Ps Price to Sales ratio BLUE's Sales per Employee BLUE's Asset Turnover Ratio
BLUE's Net Margin BLUE's Pb Price to Book ratio BLUE's Financial Strength Ratios BLUE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Pro dex Inc   2.49 $ 44.015  Millions$ 18  Millions
Dariohealth Corp   2.49 $ 12.000  Millions$ 5  Millions
Lifevantage Corp  2.48 $ 43.000  Millions$ 17  Millions
Icu Medical Inc  2.46 $ 1,570.264  Millions$ 637  Millions
Perrigo Company Plc  2.46 $ 2,757.000  Millions$ 1,122  Millions
Amphastar Pharmaceuticals Inc   2.44 $ 361.653  Millions$ 148  Millions
Kiniksa Pharmaceuticals International Plc  2.44 $ 68.195  Millions$ 28  Millions
Eton Pharmaceuticals Inc   2.43 $ 20.000  Millions$ 8  Millions
Orthofix Medical Inc   2.43 $ 266.509  Millions$ 109  Millions
Sunshine Biopharma Inc   2.43 $ 25.189  Millions$ 10  Millions
Merck and Co Inc   2.41 $ 15,072.000  Millions$ 6,255  Millions
X4 Pharmaceuticals Inc  2.40 $ 5.513  Millions$ 2  Millions
Resmed Inc   2.38 $ 2,040.000  Millions$ 856  Millions
Nuo Therapeutics Inc   2.35 $ 0.373  Millions$ 0  Millions
Merit Medical Systems Inc  2.35 $ 725.475  Millions$ 308  Millions
Biomerica Inc   2.35 $ 4.912  Millions$ 2  Millions
Neogen Corporation  2.34 $ 462.312  Millions$ 198  Millions
10x Genomics Inc   2.32 $ 196.950  Millions$ 85  Millions
Encision Inc   2.28 $ 3.044  Millions$ 1  Millions
Hologic Inc  2.27 $ 1,574.600  Millions$ 692  Millions
Johnson and Johnson  2.27 $ 28,317.000  Millions$ 12,469  Millions
Viatris Inc   2.27 $ 9,049.400  Millions$ 3,994  Millions
Embecta Corp   2.25 $ 393.000  Millions$ 174  Millions
Creative Medical Technology Holdings Inc   2.25 $ 0.006  Millions$ 0  Millions
Bio techne Corp  2.24 $ 412.751  Millions$ 184  Millions
Lifecore Biomedical Inc   2.24 $ 86.989  Millions$ 39  Millions
Allurion Technologies Inc   2.23 $ 9.000  Millions$ 4  Millions
Evofem Biosciences Inc   2.21 $ 3.515  Millions$ 2  Millions
Accuray Incorporated  2.20 $ 317.451  Millions$ 144  Millions
Waters Corporation  2.18 $ 1,106.974  Millions$ 508  Millions

Date modified: 2026-08-29T17:19:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.